Compounds > tolbutamide
Page last updated: 2024-08-16

tolbutamide and dihydropyridines

tolbutamide has been researched along with dihydropyridines in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Findlay, I3
Rustenbeck, I; Seemann, N; Welling, A1

Other Studies

4 other study(ies) available for tolbutamide and dihydropyridines

ArticleYear
Inhibition of ATP-sensitive K+ channels in cardiac muscle by the sulphonylurea drug glibenclamide.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 261, Issue:2

    Topics: Adenosine Triphosphate; Animals; Benzopyrans; Dihydropyridines; Glyburide; Guinea Pigs; Heart Ventricles; Muscle, Smooth, Vascular; Potassium Channels; Tolbutamide; Vasodilator Agents

1992
Effects of pH upon the inhibition by sulphonylurea drugs of ATP-sensitive K+ channels in cardiac muscle.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 262, Issue:1

    Topics: Adenosine Triphosphate; Animals; Benzopyrans; Dihydropyridines; Drug Interactions; Glyburide; Guinea Pigs; Hydrogen-Ion Concentration; Kinetics; Membrane Potentials; Muscle, Smooth, Vascular; Potassium Channels; Tolbutamide; Vasodilator Agents

1992
Sulphonylurea drugs no longer inhibit ATP-sensitive K+ channels during metabolic stress in cardiac muscle.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:1

    Topics: Adenosine Triphosphate; Animals; Benzopyrans; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cells, Cultured; Dihydropyridines; Dinitrophenols; Glyburide; Heart; Membrane Potentials; Myocardial Contraction; Myocardium; Potassium Channels; Rats; Sensitivity and Specificity; Stress, Physiological; Sulfonylurea Compounds; Tolbutamide

1993
The inhibitor of connexin Cx36 channels, mefloquine, inhibits voltage-dependent Ca
    Molecular and cellular endocrinology, 2018, 09-05, Volume: 472

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Connexins; Dihydropyridines; Gap Junction delta-2 Protein; Glucose; Insulin Secretion; Insulin-Secreting Cells; Ion Channel Gating; Mefloquine; Mice; Nisoldipine; Potassium Chloride; Tolbutamide

2018